Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_008b3cd08be2cebb0ed30e54242e5128 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b89ec2e5e452f22454d6a8fff717305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e57ad6f37525e46167a4e27bd1f13fd3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2b46e05f9bbd846aa4d07ff31a59d82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_821af6a61f1a11343ee8d2b1b5025d17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a177b168286697152ce537e277ed8ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ae9027ae7c2742ca8eb31775dfda74c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a786acb13a012877a2e1fdde8d7b99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53b79f6219fe2108e04b01c93b05481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e78388ab5bda56425375221aaaf01ea4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1548dfabe1d37a5f090254c61c80ddb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ac90f73547c4b7aa90d9f99aecb762 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13eb99555820771e71e889f8b3408c89 |
publicationDate |
2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012129365-A1 |
titleOfInvention |
Myelin regeneration with androgens |
abstract |
Methods for effective remyelination in patients are disclosed comprising treating the patient with an androgen receptor ligand which exerts binding to androgen receptors and elicits androgen-receptor-induced biological responses at a dosage sufficient to induce remyelination. The androgen compound preferably comprises MENT in an androgen targeting both androgen and estrogen receptors, and the methods include combining the androgen compound with a progestin compound in order to provide both contraception in men and treatment for neurodegeneration. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723911-B2 |
priorityDate |
2011-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |